IMMUCELL CORP /DE/ (ICCC)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, IMMUCELL CORP /DE/ reported revenue of $27.64M, up 4.3% from the prior year. The company ran a net loss, with a net margin of -3.8% and a gross margin of 41.4%. It held $42.53M in total assets against $15.48M in total liabilities.
Key ratios (FY2025)
41.4%
Gross margin
6.0%
Operating margin
-3.8%
Net margin
-3.8%
Return on equity
+4.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.64M | $26.49M | $17.47M | $18.57M | — | — | — | — | — | — |
| Cost of Revenue | $16.20M | $18.55M | — | — | — | — | — | — | — | — |
| Gross Profit | $11.45M | $7.94M | $3.87M | $7.65M | $8.66M | $6.86M | $6.74M | $5.19M | $5.22M | $5.42M |
| Operating Income | $1.65M | -$1.64M | -$5.75M | -$2.30M | $257.4K | -$1.38M | -$953.9K | -$1.45M | -$242.8K | $890.2K |
| Net Income | -$1.04M | -$2.16M | -$5.77M | -$2.49M | -$78.3K | -$1.02M | -$1.30M | -$2.32M | -$168.1K | $508.4K |
| EPS (Diluted) | $-0.12 | $-0.26 | $-0.75 | $-0.32 | $-0.01 | $-0.14 | $-0.19 | $-0.42 | $-0.03 | $0.12 |
| Total Assets | $42.53M | $45.10M | $43.81M | $44.86M | $44.47M | $40.35M | $38.69M | $32.73M | $34.30M | $24.70M |
| Total Liabilities | $15.48M | $17.58M | $18.82M | $14.48M | $11.89M | $12.08M | $9.70M | $10.99M | $10.70M | $4.98M |
| Shareholders' Equity | $27.06M | $27.52M | $24.99M | $30.38M | $32.58M | $28.27M | $28.99M | $21.74M | $23.59M | $19.72M |
| Cash & Equivalents | $3.81M | $3.76M | $978.7K | $5.79M | $10.19M | $6.95M | $6.29M | $2.52M | $3.80M | $5.15M |
| Operating Cash Flow | $2.48M | $357.9K | -$4.67M | -$1.54M | $954.2K | $1.32M | $233.5K | -$373.4K | $1.18M | -$222.3K |
| Capital Expenditures | $1.25M | $465.7K | $1.89M | $3.98M | $2.61M | $4.07M | $1.39M | $2.03M | $17.76M | $3.59M |
| Shares Outstanding | 9.03M | 8.17M | 7.75M | 7.75M | 7.59M | 7.21M | 6.82M | 5.49M | 4.95M | 4.34M |